EFFICACY OF THE COMPLEMENT INHIBITOR ECULIZUMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS NEVER TRANSFUSED

被引：0
|
作者：
Risitano, A. [1 ]
Alfinito, F. [1 ]
Seneca, E. [1 ]
Marando, L. [1 ]
Boschetti, C. [2 ]
Bonfigli, S. [3 ]
Fenu, S. [4 ]
Re, F. [5 ]
Gosetti, G. [6 ]
Khursigara, G.
Rother, R.
Zanella, A. [2 ]
Rotoli, B. [1 ]
机构：
[1] Univ Naples Federico II, Naples, Italy
[2] Osped Policlin Maggiore, IRCCS, Milan, Italy
[3] Univ Sassari, I-07100 Sassari, Italy
[4] S Giovanni Addolorata Hosp, Rome, Italy
[5] Univ Parma, I-43100 Parma, Italy
[6] Santa Chiara Hosp, Trento, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0581
引用
收藏
页码：237 / 237
页数：1
相关论文
共 50 条
  • [31] Survival benefit of eculizumab in patients with paroxysmal nocturnal hemoglobinuria
    Patel, Ami
    Metzger, Jesse
    Terriou, Louis
    Patriquin, Christopher
    Griffin, Morag
    Lee, Jong Wook
    Gustovic, Phillippe
    Jiang, Wei
    Szer, Jeff
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 264 - 265
  • [32] Eculizumab in the Treatment of Paroxysmal Nocturnal Hemoglobinuria
    Hill, Anita
    [J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1467 - 1476
  • [33] Eculizumab (Soliris) for paroxysmal nocturnal hemoglobinuria
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2007, 49 (1270): : 79 - 80
  • [34] Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab
    Alashkar, Ferras
    Vance, Colin
    Herich-Terhuerne, Doerte
    Preising, Nicole
    Duehrsen, Ulrich
    Roeth, Alexander
    [J]. ANNALS OF HEMATOLOGY, 2017, 96 (04) : 589 - 596
  • [35] Serologic Response to Meningococcal Vaccination in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) for the Chronic Treatment with the Terminal Complement Inhibitor Eculizumab
    Roeth, Alexander
    Alashkar, Ferras
    Herich-Terhuerne, Doerte
    Elias, Johannes
    Vogel, Ulrich
    Duehrsen, Ulrich
    [J]. BLOOD, 2014, 124 (21)
  • [36] Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab
    Ferras Alashkar
    Colin Vance
    Dörte Herich-Terhürne
    Nicole Preising
    Ulrich Dührsen
    Alexander Röth
    [J]. Annals of Hematology, 2017, 96 : 589 - 596
  • [37] Paroxysmal Nocturnal Hemoglobinuria With Budd-Chiari Syndrome Treated With Complement Inhibitor Eculizumab; A Case Report
    Valeri, Federica
    Borchiellini, Alessandra
    Schinco, Piercarla
    Boccadoro, Mario
    [J]. BLOOD, 2013, 122 (21)
  • [38] The Change of Complement Deposition after Complement Inhibitor Treatment in Paroxysmal Nocturnal Hemoglobinuria Patients
    Zhang, Menglu
    Wang, Xuan
    Yang, Chen
    Chen, Miao
    Zhuang, Junling
    Han, Bing
    [J]. BLOOD, 2023, 142
  • [39] Safety and efficacy of eculizumab with concomitant erythropoietin therapy in patients with paroxysmal nocturnal hemoglobinuria (PNH)
    Mojcik, C. F.
    Young, N. S.
    Luzzatto, L.
    Socie, G.
    Hillmen, P.
    Brodsky, R. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [40] The complement in paroxysmal nocturnal hemoglobinuria
    PorcelPerez, JM
    RubioCaballero, MR
    [J]. REVISTA CLINICA ESPANOLA, 1996, 196 : 31 - 35
12345